David J. Hawkes

David J. Hawkes

Auto-generated profile, based on publicly available information

David J. Hawkes

Centre for Medical Image Computing, University College London, London, UK

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2020 in American Journal of Respiratory and Critical Care Medicine
Verified
Journal Article
Closed access
AYAlexandra L. Young
Alexandra L. Young
FBFelix J. S. Bragman
Felix J. S. Bragman
BRBojidar Rangelov
Bojidar Rangelov
MHMeiLan K. Han
MeiLan K. Han
CGCraig J. Galbán
Craig J. Galbán
JHJohn Hurst
John Hurst
Rationale: The decades-long progression of chronic obstructive pulmonary disease (COPD) renders identifying different trajectories of disease progression challenging. Objectives: To identify subtypes of patients with COPD with distinct longitudinal progression patterns using a novel machine-learning tool called “Subtype and Stage Inference” (SuStaIn) and to evaluate the utility of SuStaIn for patient stratification in COPD. Methods: We applied SuStaIn to cross-sectional computed tomography imaging markers in 3,698 Global Initiative for Chronic Obstructive Lung Disease (GOLD) 1–4 patients and 3,479 controls from the COPDGene (COPD Genetic Epidemiology) study to identify subtypes of patients with COPD. We confirmed the identified subtypes and progression patterns using ECLIPSE (Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints) data. We assessed the utility of SuStaIn for patient stratification by comparing SuStaIn subtypes and stages at baseline with longitudinal follow-up data. Measurements and Main Results: We identified two trajectories of disease progression in COPD: a “Tissue→Airway” subtype (n = 2,354, 70.4%), in which small airway dysfunction and emphysema precede large airway wall abnormalities, and an “Airway→Tissue” subtype (n = 988, 29.6%), in which large airway wall abnormalities precede emphysema and small airway dysfunction. Subtypes were reproducible in ECLIPSE. Baseline stage in both subtypes correlated with future FEV1/FVC decline (r = −0.16 [P < 0.001] in the Tissue→Airway group; r = −0.14 [P = 0.011] in the Airway→Tissue group). SuStaIn placed 30% of smokers with normal lung function at elevated stages, suggesting imaging changes consistent with early COPD. Individuals with early changes were 2.5 times more likely to meet COPD diagnostic criteria at follow-up. Conclusions: We demonstrate two distinct patterns of disease progression in COPD using SuStaIn, likely representing different endotypes. One third of healthy smokers have detectable imaging changes, suggesting a new biomarker of “early COPD.”

1 September 2021 in Surgical Oncology
Verified
Journal Article
Closed access
CSC. Schneider
C. Schneider
MAM. Allam
M. Allam
DSD. Stoyanov
D. Stoyanov
DHD.J. Hawkes
D.J. Hawkes
KGK. Gurusamy
K. Gurusamy
Brian DavidsonBrian Davidson
Brian Davidson

10 January 2011 in Medical Physics
Verified
Journal Article
Closed access
CTChristine Tanner
Christine Tanner
MWMark White
Mark White
SGSalvatore Guarino
Salvatore Guarino
MHMargaret A. Hall‐Craggs
Margaret A. Hall‐Craggs
MDMichael Douek
Michael Douek
DHDavid J. Hawkes
David J. Hawkes

21 June 2016 in IEEE Transactions on Biomedical Engineering
Verified
Journal Article
Open access
YHYipeng Hu
Yipeng Hu
VKVeeru Kasivisvanathan
Veeru Kasivisvanathan
LSLucy A. M. Simmons
Lucy A. M. Simmons
MCMatthew J. Clarkson
Matthew J. Clarkson
STStephen A. Thompson
Stephen A. Thompson
DBDean C. Barratt
Dean C. Barratt
Objective: Three- and four-dimensional transrectal ultrasound transducers are now available from most major ultrasound equipment manufacturers, but currently are incorporated into only one commercial prostate biopsy guidance system. Such transducers offer the benefits of rapid volumetric imaging, but can cause substantial measurement distortion in electromagnetic tracking sensors, which are commonly used to enable 3-D navigation. In this paper, we describe the design, development, and validation of a 3-D-ultrasound-guided transrectal prostate biopsy system that employs high-accuracy optical tracking to localize the ultrasound probe and prostate targets in 3-D physical space. Methods: The accuracy of the system was validated by evaluating the targeted needle placement error after inserting a biopsy needle to sample planned targets in a phantom using standard 2-D ultrasound guidance versus real-time 3-D guidance provided by the new system. Results: The overall mean needle-segment-to-target distance error was 3.6 ± 4.0 mm and mean needle-to-target distance was 3.2 ± 2.4 mm. Conclusion: A significant increase in needle placement accuracy was observed when using the 3-D guidance system compared with visual targeting of invisible (virtual) lesions using a standard B-mode ultrasound-guided biopsy technique.

1 January 2020 in International Journal of Chronic Obstructive Pulmonary Disease
Verified
Journal Article
Open access
PDF file
BRBojidar A Rangelov
Bojidar A Rangelov
AYAlexandra L Young
Alexandra L Young
JJJoseph Jacob
Joseph Jacob
ACAnthony P Cahn
Anthony P Cahn
SLSarah Lee
Sarah Lee
JHJohn Hurst
John Hurst
Exacerbations of chronic obstructive pulmonary disease (COPD) are currently diagnosed based on changes in respiratory symptoms. Characterizing the imaging manifestation of exacerbations could be useful for objective diagnosis of exacerbations in the clinic and clinical trials, as well as provide a mechanism for monitoring exacerbation treatment and recovery. In this systematic review, we employed a comprehensive search across three databases (Medline, EMBASE, Web of Science) to identify studies that performed imaging of the thorax at COPD exacerbation. We included 51 from a total of 5,047 articles which met all our inclusion criteria. We used an adapted version of the Modified Newcastle-Ottawa Quality Assessment Scale for cohort studies to assess the quality of the included studies. Conclusions were weighted towards higher-quality articles. We identified a total of 36 thoracic imaging features studied at exacerbation of COPD. Studies were generally heterogeneous in their measurements and focus. Nevertheless, considering studies which performed consecutive imaging at stable state and exacerbation, which scored highest for quality, we identified salient imaging biomarkers of exacerbations. An exacerbation is characterized by airway wall and airway calibre changes, hyperinflation, pulmonary vasoconstriction and imaging features suggestive of pulmonary arterial hypertension. Most information was gained from CT studies. We present the first ever composite imaging signature of COPD exacerbations. While imaging during an exacerbation is comparatively new and not comprehensively studied, it may uncover important insights into the acute pathophysiologic changes in the cardiorespiratory system during exacerbations of COPD, providing objective confirmation of events and a biomarker of recovery and treatment response.

2 March 2018
Verified
Conference Paper
Open access
PDF file
KQKin Quan
Kin Quan
RSRebecca J. Shipley
Rebecca J. Shipley
RTRyutaro Tanno
Ryutaro Tanno
GMGraeme McPhillips
Graeme McPhillips
VVVasileios Vavourakis
Vasileios Vavourakis
DHDavid J. Hawkes
David J. Hawkes
Bronchiectasis is the permanent dilation of airways. Patients with the disease can suffer recurrent exacerbations, reducing their quality of life. The gold standard to diagnose and monitor bronchiectasis is accomplished by inspection of chest computed tomography (CT) scans. A clinician examines the broncho-arterial ratio to determine if an airway is brochiectatic. The visual analysis assumes the blood vessel diameter remains constant, although this assumption is disputed in the literature. We propose a simple measurement of tapering along the airways to diagnose and monitor bronchiectasis. To this end, we constructed a pipeline to measure the cross-sectional area along the airways at contiguous intervals, starting from the carina to the most distal point observable. Using a phantom with calibrated 3D printed structures, the precision and accuracy of our algorithm extends to the sub voxel level. The tapering measurement is robust to bifurcations along the airway and was applied to chest CT images acquired in clinical practice. The result is a statistical difference in tapering rate between airways with bronchiectasis and controls.